Skip to main content
. 2021 Jul 21;15:684019. doi: 10.3389/fnbot.2021.684019

Table 2.

Overall treatment analysis.

Assessment Before the treatment After the treatment p-value
WMFT, median time, seconds 93.6 (67.76−316.9) 76.96 (50.02−197,98) 0.011
FMA—UL 51 (45−57) 56.5 (49−62) <0.001
WMFT (Ability), score 3.6 (2.8−3.87) 3.93 (3.26−4.47) <0.001
AMAT (Ability), score 3.5 (2.69−4) 3.81 (3.24−4.65) <0.001
AMAT (Quality), score 2.97 (2.24−3.65) 3.55 (2.86−4.10) <0.001
MAS, score 0.17 (0−0.5) 0.11 (0−0.28) 0.005
FIM, score 77 (71−80) 79.5 (78−81) <0.001
SIS (total score) 65.32 (55.79−72.34) 73.56 (62.83−79.31) <0.001
    SIS strength 56.25 (37.5−75) 62.5 (50−75) 0.075
    SIS Activities of Daily Living 63.75 (47.5−77.5) 75 (60−82.5) <0.001
    SIS Hand Function 30 (5−45) 55 (35−65) <0.001

CIMT and RT combined.

CMIT, constraint-induced movement therapy; CI95%, 95% confidence interval; WMFT, Wolf Motor Function Test; FMA—UL, Upper Limb Fugl Meyer Assessment; AMAT, Arm Motor Ability Test; MAS, Modified Ashworth Scale; FIM, Functional Independence Measure; SIS, Stroke Impact Scale;

Median, interquartile range.

The bold values are the statistically significant p-values.